PIFELTRO

Merck Canada Inc🇨🇦 Health Canada

Approval Id: a0db5ecfeac2f814
Drug Approval Canada Name: PIFELTRO
Product Name: PIFELTRO
Status: Marketed
Status Date: 2018-11-14
Original Market Date: 2018-11-14
Din: 02481545
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.16
Atc Original: J05AG06 DORAVIRINE
Atc Name: j 05 ag 06
Aig Number: 0160730001
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

DORAVIRINE

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a0db5ecfeac2f814

Type

Standard